Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillation.

Collaborative network External validation Patient-level prediction Prognostic model Transportability

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
06 05 2020
Historique:
received: 09 07 2019
accepted: 23 04 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 25 6 2021
Statut: epublish

Résumé

To demonstrate how the Observational Healthcare Data Science and Informatics (OHDSI) collaborative network and standardization can be utilized to scale-up external validation of patient-level prediction models by enabling validation across a large number of heterogeneous observational healthcare datasets. Five previously published prognostic models (ATRIA, CHADS The five existing models were able to be integrated into the OHDSI framework for patient-level prediction and they obtained mean c-statistics ranging between 0.57-0.63 across the 6 databases with sufficient data to predict stroke within 1 year of initial atrial fibrillation diagnosis for females with atrial fibrillation. This was comparable with existing validation studies. The validation network study was run across nine datasets within 60 days once the models were replicated. An R package for the study was published at https://github.com/OHDSI/StudyProtocolSandbox/tree/master/ExistingStrokeRiskExternalValidation. This study demonstrates the ability to scale up external validation of patient-level prediction models using a collaboration of researchers and a data standardization that enable models to be readily shared across data sites. External validation is necessary to understand the transportability or reproducibility of a prediction model, but without collaborative approaches it can take three or more years for a model to be validated by one independent researcher. In this paper we show it is possible to both scale-up and speed-up external validation by showing how validation can be done across multiple databases in less than 2 months. We recommend that researchers developing new prediction models use the OHDSI network to externally validate their models.

Sections du résumé

BACKGROUND
To demonstrate how the Observational Healthcare Data Science and Informatics (OHDSI) collaborative network and standardization can be utilized to scale-up external validation of patient-level prediction models by enabling validation across a large number of heterogeneous observational healthcare datasets.
METHODS
Five previously published prognostic models (ATRIA, CHADS
RESULTS
The five existing models were able to be integrated into the OHDSI framework for patient-level prediction and they obtained mean c-statistics ranging between 0.57-0.63 across the 6 databases with sufficient data to predict stroke within 1 year of initial atrial fibrillation diagnosis for females with atrial fibrillation. This was comparable with existing validation studies. The validation network study was run across nine datasets within 60 days once the models were replicated. An R package for the study was published at https://github.com/OHDSI/StudyProtocolSandbox/tree/master/ExistingStrokeRiskExternalValidation.
CONCLUSION
This study demonstrates the ability to scale up external validation of patient-level prediction models using a collaboration of researchers and a data standardization that enable models to be readily shared across data sites. External validation is necessary to understand the transportability or reproducibility of a prediction model, but without collaborative approaches it can take three or more years for a model to be validated by one independent researcher. In this paper we show it is possible to both scale-up and speed-up external validation by showing how validation can be done across multiple databases in less than 2 months. We recommend that researchers developing new prediction models use the OHDSI network to externally validate their models.

Identifiants

pubmed: 32375693
doi: 10.1186/s12874-020-00991-3
pii: 10.1186/s12874-020-00991-3
pmc: PMC7201646
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102

Subventions

Organisme : NLM NIH HHS
ID : R01 LM011369
Pays : United States
Organisme : Health Promotion Administration, Ministry of Health and Welfare (TW)
ID : HI16C0992
Pays : International
Organisme : Innovative Medicines Initiative Joint Undertaking
ID : 806968
Pays : International

Références

J Clin Epidemiol. 2015 Jan;68(1):25-34
pubmed: 25441703
J Am Heart Assoc. 2013 Jun 21;2(3):e000250
pubmed: 23782923
Int J Stroke. 2015 Feb;10(2):231-44
pubmed: 25491651
BMJ. 2013 May 02;346:f2573
pubmed: 23641033
N Engl J Med. 2016 Sep 29;375(13):1216-9
pubmed: 27682033
Heart Rhythm. 2016 Jan;13(1):46-53
pubmed: 26277496
J Am Med Inform Assoc. 2019 Dec 1;26(12):1651-1654
pubmed: 31373357
J Thromb Haemost. 2011 Jan;9(1):39-48
pubmed: 21029359
J Am Med Inform Assoc. 2018 Aug 1;25(8):969-975
pubmed: 29718407
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
JRSM Cardiovasc Dis. 2017 Jan 01;6:2048004016687211
pubmed: 28286646
JAMA. 2001 Jun 13;285(22):2864-70
pubmed: 11401607
JAMA. 2003 Aug 27;290(8):1049-56
pubmed: 12941677
Stud Health Technol Inform. 2015;216:574-8
pubmed: 26262116
J Am Coll Cardiol. 2015 Oct 27;66(17):1851-9
pubmed: 26493655
Eur Heart J. 2016 Nov 07;37(42):3203-3210
pubmed: 26941204
BMJ. 2009 May 28;338:b605
pubmed: 19477892

Auteurs

Jenna M Reps (JM)

Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. jreps@its.jnj.com.

Ross D Williams (RD)

Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Seng Chan You (SC)

Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.

Thomas Falconer (T)

Department of Biomedical Informatics, Columbia University Medical Center, New York, USA.

Evan Minty (E)

O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.

Alison Callahan (A)

Center for Biomedical Informatics Research, School of Medicine, Stanford University, Stanford, CA, USA.

Patrick B Ryan (PB)

Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.

Rae Woong Park (RW)

Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.
Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.

Hong-Seok Lim (HS)

Department of Cardiology, Ajou University Medical Centre, Suwon, Republic of Korea.

Peter Rijnbeek (P)

Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH